Therefore, we speculate that a possible immune evasion mechanism in laryngeal cancer is that tumor cells inhibit the low expression of KLRK1 by producing soluble NKG2DLs, and that a lower level of soluble NKG2DLs can lead to immune evasion. Here, KLRK1 is linked to neoplasm.